Release 5 Preview #3

This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationadministration0310.json

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Device, Encounter, Patient, Practitioner, RelatedPerson

Raw JSON (canonical form + also see JSON Format Specification)

Oral Chemotherapy - Myleran

{
  "resourceType": "MedicationAdministration",
  "id": "medadmin0310",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>id</b>: medadmin0310</p><p><b>status</b>: completed</p><p><b>medication</b>: </p><p><b>subject</b>: <a>Donald Duck. Generated Summary: id: pat1; Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male; </a></p><p><b>occurence</b>: 16/01/2015 8:03:00 AM --&gt; 16/01/2015 12:03:00 PM</p><h3>Performers</h3><table><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a>Patrick Pump. Generated Summary: id: f007; id: 874635264 (OFFICIAL), id: 567IUI51C154 (USUAL); Simone Heps (OFFICIAL); ph: 020556936(WORK), S.M.Heps@bmc.nl(WORK), fax: 0205669283(WORK); gender: female; birthDate: 1971-11-07</a></td></tr></table><p><b>request</b>: <a>Generated Summary: id: medrx0306; id: 12345689 (OFFICIAL); status: active; intent: order; <span>Myleran 2mg tablet</span>; authoredOn: 2015-01-15; <span>Chronic myeloid Leukemia (disorder)</span>; </a></p><h3>Dosages</h3><table><tr><td>-</td><td><b>Text</b></td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td>*</td><td>6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count.  With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL</td><td><span>Oral route (qualifier value)</span></td><td>6 mg</td></tr></table></div>"
  },
  "contained": [
    {
      "resourceType": "Medication",
      "id": "med0304",
      "code": {
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/ndc",
            "code": "76388-713-25",
            "display": "Myleran 2mg tablet, film coated"
          }
        ]
      }
    }
  ],
  "status": "completed",
  "medication": {
    "reference": {
      "reference": "#med0304"
    }
  },
  "subject": {
    "reference": "Patient/pat1",
    "display": "Donald Duck"
  },
  "occurencePeriod": {
    "start": "2015-01-15T22:03:00+01:00",
    "end": "2015-01-16T02:03:00+01:00"
  },
  "performer": [
    {
      "actor": {
        "reference": "Practitioner/f007",
        "display": "Patrick Pump"
      }
    }
  ],
  "request": {
    "reference": "MedicationRequest/medrx0306"
  },
  "dosage": {
    "text": "6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count.  With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL",
    "route": {
      "coding": [
        {
          "system": "http://snomed.info/sct",
          "code": "26643006",
          "display": "Oral route (qualifier value)"
        }
      ]
    },
    "dose": {
      "value": 6,
      "unit": "mg",
      "system": "http://unitsofmeasure.org",
      "code": "mg"
    }
  }
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.